Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exhalomics for Phenotyping and Real-Time Stratification in Acute Myeloid Leukaemia (EXHALE)

NCT07826897 is registered in ClinicalTrials.gov with Jeremy Deuel as lead sponsor.

NCT NCT07826897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07826897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exhalomics for Phenotyping and Real-Time Stratification in Acute Myeloid Leukaemia (EXHALE)
Lead sponsor
Jeremy Deuel
Phase
Observational
Overall status
Not yet recruiting
Start date
September 21, 2026
Completion date
August 31, 2029
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aml